Will Robert F. Kennedy Jr. leaves HHS Secretary in before 2027?
🗂 Part of event: Who will leave their role in the Trump administration in 2026? →💡 What the odds say
The market puts this at about a 26% chance — unlikely.
No money — just record your call and see if you were right. Yes is at 26% right now.
RFK Jr. is entrenching his position through policy wins, but the market prices in a 26% departure chance, suggesting skepticism about the sustainability of his controversial agenda.
What's driving it
- • RFK Jr.'s handpicked committee approving peptide manufacture (Ars Technica, Jul 24) demonstrates his control over HHS, reducing departure odds.
- • Progress on stopping suppression of controversial drugs (Politico, Jul 24) indicates he is fulfilling his agenda, which typically correlates with job security.
- • Sweeping changes to US vaccine policy (Ukraine News, Jul 25) show he is deeply engaged in his role, making early departure less likely.
- • Scientists' objections to peptide restrictions (NYT, Jul 24; Washington Post, Jul 24) highlight the controversy surrounding his agenda, which maintains a baseline risk of departure.
The case for YES
- • His push for controversial drugs and peptides (Politico, Jul 24; NYT, Jul 24) could generate political backlash or legal challenges that force his resignation.
- • The appearance of conflicts of interest with companies tied to his movement (Financial Times, Jul 25) might lead to ethics investigations and departure.
- • Sweeping changes to vaccine policy (Ukraine News, Jul 25) could provoke public outcry or congressional action, increasing the chance of removal.
The case for NO
- • His handpicked committee approving peptide manufacture (Ars Technica, Jul 24) shows he has consolidated power within HHS, making it unlikely he will leave soon.
- • Making progress on stopping suppression of controversial drugs (Politico, Jul 24) indicates he is achieving his goals, which reduces the incentive to resign.
- • Pushing sweeping changes to vaccine policy (Ukraine News, Jul 25) demonstrates he is actively shaping policy, suggesting he intends to stay in office.
What to watch
- • The FDA's final decision on peptide restrictions, expected within months of the panel recommendation (NYT, Jul 24), would be a catalyst; a restrictive rule would increase Yes odds, while a permissive rule would decrease them.
- • Any announcement of a congressional investigation into RFK Jr.'s vaccine policy changes (Ukraine News, Jul 25) would likely increase Yes odds, but no specific date is known.
AI-generated · grounded in recent news + odds · informational only, not advice. Verify on the source platform.
Data from Kalshi’s public API, for informational purposes only. PredictPal is not affiliated with any platform and does not facilitate trading.
Discussion
Loading…
How it resolves
Settled by Kalshi, a CFTC-regulated US exchange, against the official source named in each contract (e.g. a government release or election certification), with an Outcome Review Committee as a backstop for disputes.
Resolution criteria
If Robert F. Kennedy Jr. leaves as HHS Secretary before 2027, then the market resolves to Yes.
ⓘ A market settles under its own written rules, which can lag what looks decided in the news — so the price may not move to 100% the moment an outcome seems obvious.
View the official rules on Kalshi ↗Related markets
Will Trump announce he is running for President in the 2028 election?
Yes ≈ 56% chance
Will the U.S. invade Iran before 2027?
Despite ongoing regional tensions, the US is actively de-escalating, with President Trump holding off on strikes against Iran for the first time in two weeks, causing invasion odds to drop sharply.
Yes ≈ 20% chance